Press Digest: Wall Street Journal - October 26
PRESS DIGEST-Wall Street Journal - October 26 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
- Australia's Ingenia Communities INA.AX revoked Warburg Pincus’s data-room access after receiving a rival $1.55 billion takeover offer from AVID Property Group.
- Swiss drugmaker Roche ROPC.S said its experimental lung cancer drug divarasib reduced the risk of death by 44% compared with existing treatments in a phase III study.
- AstraZeneca AZN.L is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market.
(Compiled by Bengaluru newsroom)
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)